Scott Daniel Cormack Insider Trading $ACHV ACHIEVE LIFE SCIENCES, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Daniel Cormack.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Daniel Cormack. Scott Daniel Cormack is Director in ACHIEVE LIFE SCIENCES, INC. ($OGXI) and President & CEO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and President and CEO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI).
Scott Daniel Cormack in ACHIEVE LIFE SCIENCES, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Scott Daniel Cormack: Director, President and CEO, President & CEO
Holdings: 14,810 shares
Current Value: $8,886
Latest Transaction: May 14 2020
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Scott Daniel Cormack in ACHIEVE LIFE SCIENCES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
| May 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 4.02 | 7,000 | 28,140 | 7,000 | |
| Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
| Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Payment of Exercise | F | 3.09 | 1,491 | 4,607 | 14,810 | 16.3 K to 14.8 K (-9.15 %) |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 4.57 | 11,000 | 50,270 | 11,000 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 454 | 0 | 0 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 852 | 0 | 0 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 284 | 0 | 0 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 852 | 0 | 0 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 1,705 | 0 | 0 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 568 | 0 | 0 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Buy | M | 0.00 | 1,590 | 0 | 9,685 | 8.1 K to 9.7 K (+19.64 %) |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Buy | M | 0.00 | 3,125 | 0 | 16,302 | 13.2 K to 16.3 K (+23.72 %) |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 9,375 | |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 5,000 | 0 | 89,055 | 84.1 K to 89.1 K (+5.95 %) |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.36 | 4,472 | 1,610 | 144,953 | 149.4 K to 145 K (-2.99 %) |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 9,375 | 0 | 149,425 | 140.1 K to 149.4 K (+6.69 %) |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 18,750 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 0 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 10,312 | 0 | 84,055 | 73.7 K to 84.1 K (+13.98 %) |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.63 | 9,690 | 6,105 | 140,050 | 149.7 K to 140.1 K (-6.47 %) |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 20,312 | 0 | 149,740 | 129.4 K to 149.7 K (+15.69 %) |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 18,750 | |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 5,000 | 0 | 73,743 | 68.7 K to 73.7 K (+7.27 %) |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 1.03 | 4,856 | 4,979 | 129,428 | 134.3 K to 129.4 K (-3.62 %) |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 9,375 | 0 | 134,284 | 124.9 K to 134.3 K (+7.51 %) |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.85 | 135,000 | 114,750 | 135,000 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.85 | 300,000 | 255,000 | 300,000 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 28,125 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 12,500 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 4,687 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 0 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 0.83 | 12,033 | 9,987 | 124,909 | 136.9 K to 124.9 K (-8.79 %) |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 25,000 | 0 | 136,942 | 111.9 K to 136.9 K (+22.33 %) |
| Jun 16 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 28,125 | |
| Jun 16 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 2.69 | 4,571 | 12,296 | 111,942 | 116.5 K to 111.9 K (-3.92 %) |
| Jun 16 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 9,375 | 0 | 116,513 | 107.1 K to 116.5 K (+8.75 %) |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 1.86 | 75,000 | 139,500 | 75,000 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 4,687 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 1.88 | 7,543 | 14,181 | 107,138 | 114.7 K to 107.1 K (-6.58 %) |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 15,624 | 0 | 114,681 | 99.1 K to 114.7 K (+15.77 %) |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 4.11 | 46,137 | 189,517 | 46,137 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 6,855 | 26,676 | 6,855 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 21,545 | 83,842 | 21,545 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 6,528 | 25,404 | 6,528 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 20,457 | 79,608 | 20,457 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 7,073 | 27,525 | 7,073 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 870 | 3,386 | 870 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 24,809 | 96,544 | 24,809 | |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Grant | A | 0.00 | 1,015 | 0 | 1,015 | 0 to 1 K |
| Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Grant | A | 0.00 | 1,306 | 0 | 1,306 | 0 to 1.3 K |
Page: 1